Pharmacolog announces upcoming change in management

The company has decided by mutual agreement that Lars Gusch will step down from his current position as CEO on April 30, 2024.

Pharmacolog announces that the currently appointed CEO Lars Gusch will step down from his position on April 30, 2024. This resignation is by mutual agreement with the Board of Directors, which in the meantime is working on the recruitment of a successor CEO, who will be announced in due course.

Lars Gusch, CEO comments: “I would like to thank the Board of Directors for the trust they have placed in me and the good cooperation. Pharmacolog has gone through challenging times in the past year and it has been an honor to lead the company. I am sure that the path we have taken will be successfully continued with new leadership after my departure and I wish the company the best of luck.”

Erik Hedlund, Chairman of the Executive Board, comments: “Lars Gusch took over as CEO of Pharmacolog in a turbulent situation for the company. It soon became clear that the conditions for running the business further were lacking. Instead of developing, Lars Gusch’s main task was to wind down the business. Lars Gusch has carried out and completed this task in an exemplary manner.

With a new direction for Pharmacolog, we have jointly decided that Lars Gusch will leave his position at the end of April this year. We wish Lars Gusch good luck in his new challenges.”

For more information contact:

Lars Gusch, CEO

Phone: +46
70-223 97 72

About Pharmacolog

Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.

The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, WasteLog™and Pharmacolog Dashboard™.

Further information regarding the company is available at

The company’s Certified Adviser is Mangold Fondkommission AB.


Send download link

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.